Gefitinib
GeneID | Mean_1 | Mean_3 | StDev_1 | StDev_3 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 19 | 3.0 | 2.4 | 0.6 | 0.1 | -1.605 | 0.2442 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
2 | 9429 | 2.8 | 6.4 | 0.5 | 0.3 | 11.391 | 0.0013 | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) |
3 | 196 | 9.6 | 8.4 | 0.3 | 0.2 | -6.697 | 0.0045 | AHR | aryl hydrocarbon receptor |
4 | 231 | 2.7 | 5.8 | 0.3 | 0.1 | 16.078 | 0.0023 | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) |
5 | 238 | 2.5 | 2.5 | 0.1 | 0.1 | 0.197 | 0.8553 | ALK | anaplastic lymphoma receptor tyrosine kinase |
6 | 481 | 10.2 | 13.5 | 0.2 | 0.1 | 24.123 | 0.0000 | ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide |
7 | 51761 | 2.8 | 4.2 | 0.2 | 0.2 | 8.068 | 0.0017 | ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 |
8 | 9212 | 8.7 | 10.0 | 0.2 | 0.2 | 7.824 | 0.0014 | AURKB | aurora kinase B |
9 | 581 | 9.5 | 9.5 | 0.3 | 0.1 | -0.257 | 0.8169 | BAX | BCL2-associated X protein |
10 | 596 | 10.3 | 10.3 | 0.2 | 0.1 | 0.739 | 0.5268 | BCL2 | B-cell CLL/lymphoma 2 |
11 | 78996 | 9.9 | 11.0 | 0.2 | 0.1 | 9.881 | 0.0048 | C7orf49 | chromosome 7 open reading frame 49 |
12 | 836 | 8.2 | 8.0 | 0.3 | 0.2 | -1.211 | 0.3082 | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
13 | 842 | 8.6 | 7.7 | 0.1 | 0.6 | -2.444 | 0.1304 | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
14 | 57332 | 9.5 | 9.0 | 0.6 | 0.3 | -1.117 | 0.3492 | CBX8 | chromobox homolog 8 |
15 | 891 | 11.3 | 12.0 | 0.1 | 0.2 | 4.535 | 0.0280 | CCNB1 | cyclin B1 |
16 | 55536 | 9.5 | 8.5 | 0.2 | 0.1 | -6.800 | 0.0050 | CDCA7L | cell division cycle associated 7-like |
17 | 1000 | 3.2 | 3.2 | 0.4 | 0.1 | 0.188 | 0.8677 | CDH2 | cadherin 2, type 1, N-cadherin (neuronal) |
18 | 1029 | 6.0 | 6.5 | 0.4 | 0.0 | 2.330 | 0.1427 | CDKN2A | cyclin-dependent kinase inhibitor 2A |
19 | 81620 | 13.0 | 13.5 | 0.6 | 0.1 | 1.278 | 0.3241 | CDT1 | chromatin licensing and DNA replication factor 1 |
20 | 1084 | 2.6 | 3.0 | 0.3 | 0.7 | 0.902 | 0.4445 | CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 |
21 | 83548 | 10.1 | 10.1 | 0.0 | 0.2 | 0.698 | 0.5574 | COG3 | component of oligomeric golgi complex 3 |
22 | 114757 | 13.4 | 13.0 | 0.1 | 0.2 | -2.755 | 0.0760 | CYGB | cytoglobin |
23 | 1558 | 2.2 | 2.8 | 0.0 | 0.6 | 1.477 | 0.2775 | CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 |
24 | 4921 | 2.6 | 2.9 | 0.4 | 0.4 | 0.964 | 0.3899 | DDR2 | discoidin domain receptor tyrosine kinase 2 |
25 | 1950 | 2.3 | 2.4 | 0.0 | 0.1 | 1.016 | 0.4144 | EGF | epidermal growth factor |
26 | 1956 | 2.9 | 3.3 | 0.2 | 0.1 | 3.112 | 0.0782 | EGFR | epidermal growth factor receptor |
27 | 1978 | 13.9 | 12.8 | 0.8 | 0.1 | -2.355 | 0.1388 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 |
28 | 1999 | 10.5 | 10.5 | 0.1 | 0.7 | 0.018 | 0.9875 | ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
29 | 27436 | 11.9 | 12.3 | 0.1 | 0.0 | 4.717 | 0.0311 | EML4 | echinoderm microtubule associated protein like 4 |
30 | 2048 | 5.7 | 5.8 | 0.3 | 0.2 | 0.700 | 0.5288 | EPHB2 | EPH receptor B2 |
31 | 2064 | 9.7 | 9.0 | 0.4 | 0.3 | -2.344 | 0.0865 | ERBB2 | erb-b2 receptor tyrosine kinase 2 |
32 | 2065 | 9.6 | 9.3 | 0.1 | 0.2 | -2.412 | 0.0886 | ERBB3 | erb-b2 receptor tyrosine kinase 3 |
33 | 2066 | 7.9 | 5.6 | 0.2 | 0.3 | -11.036 | 0.0005 | ERBB4 | erb-b2 receptor tyrosine kinase 4 |
34 | 2099 | 11.4 | 9.4 | 0.1 | 0.2 | -16.793 | 0.0003 | ESR1 | estrogen receptor 1 |
35 | 2109 | 14.1 | 14.3 | 0.2 | 0.2 | 1.350 | 0.2482 | ETFB | electron-transfer-flavoprotein, beta polypeptide |
36 | 2258 | 4.8 | 6.2 | 0.4 | 0.4 | 4.282 | 0.0135 | FGF13 | fibroblast growth factor 13 |
37 | 2321 | 2.4 | 2.5 | 0.1 | 0.1 | 0.409 | 0.7102 | FLT1 | fms-related tyrosine kinase 1 |
38 | 2335 | 4.0 | 3.7 | 1.6 | 0.6 | -0.245 | 0.8247 | FN1 | fibronectin 1 |
39 | 51053 | 12.1 | 12.6 | 0.3 | 0.4 | 1.716 | 0.1624 | GMNN | geminin, DNA replication inhibitor |
40 | 2996 | 2.3 | 2.3 | 0.0 | 0.0 | -0.435 | 0.6861 | GYPE | glycophorin E (MNS blood group) |
41 | 3014 | 13.3 | 13.7 | 0.1 | 0.2 | 2.466 | 0.0809 | H2AFX | H2A histone family, member X |
42 | 3265 | 10.7 | 10.7 | 0.2 | 0.4 | -0.278 | 0.8001 | HRAS | Harvey rat sarcoma viral oncogene homolog |
43 | 3292 | 8.9 | 8.4 | 0.1 | 0.1 | -8.250 | 0.0016 | HSD17B1 | hydroxysteroid (17-beta) dehydrogenase 1 |
44 | 3480 | 12.9 | 12.8 | 0.3 | 0.2 | -0.296 | 0.7828 | IGF1R | insulin-like growth factor 1 receptor |
45 | 3484 | 2.4 | 2.2 | 0.2 | 0.0 | -0.937 | 0.4466 | IGFBP1 | insulin-like growth factor binding protein 1 |
46 | 3486 | 6.3 | 5.5 | 0.8 | 1.0 | -1.214 | 0.2937 | IGFBP3 | insulin-like growth factor binding protein 3 |
47 | 3569 | 2.3 | 2.3 | 0.0 | 0.0 | -0.440 | 0.6964 | IL6 | interleukin 6 |
48 | 3630 | 3.6 | 4.1 | 0.4 | 0.4 | 1.716 | 0.1617 | INS | insulin |
49 | 3791 | 2.4 | 2.3 | 0.0 | 0.1 | -0.496 | 0.6472 | KDR | kinase insert domain receptor |
50 | 4214 | 11.6 | 11.1 | 0.1 | 0.1 | -4.921 | 0.0154 | MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
51 | 5595 | 8.9 | 9.2 | 0.3 | 0.1 | 1.920 | 0.1525 | MAPK3 | mitogen-activated protein kinase 3 |
52 | 4137 | 11.1 | 11.1 | 0.2 | 0.1 | -0.578 | 0.6155 | MAPT | microtubule-associated protein tau |
53 | 4233 | 9.9 | 11.6 | 0.1 | 0.1 | 28.016 | 0.0001 | MET | MET proto-oncogene, receptor tyrosine kinase |
54 | 2475 | 8.9 | 9.1 | 0.0 | 0.1 | 3.319 | 0.0559 | MTOR | mechanistic target of rapamycin (serine/threonine kinase) |
55 | 4609 | 8.9 | 8.0 | 0.4 | 0.6 | -2.174 | 0.1053 | MYC | v-myc avian myelocytomatosis viral oncogene homolog |
56 | 4691 | 15.3 | 15.0 | 0.0 | 0.3 | -1.484 | 0.2676 | NCL | nucleolin |
57 | 4780 | 3.0 | 4.4 | 0.8 | 2.1 | 1.080 | 0.3704 | NFE2L2 | nuclear factor, erythroid 2-like 2 |
58 | 7080 | 2.6 | 2.4 | 0.3 | 0.1 | -1.110 | 0.3776 | NKX2-1 | NK2 homeobox 1 |
59 | 3084 | 2.6 | 2.6 | 0.2 | 0.1 | -0.234 | 0.8278 | NRG1 | neuregulin 1 |
60 | 27065 | 2.1 | 2.1 | 0.0 | 0.0 | 0.372 | 0.7400 | NSG1 | neuron specific gene family member 1 |
61 | 10038 | 11.1 | 11.8 | 0.3 | 0.3 | 3.112 | 0.0358 | PARP2 | poly (ADP-ribose) polymerase 2 |
62 | 5077 | 2.9 | 3.2 | 0.4 | 0.3 | 1.051 | 0.3563 | PAX3 | paired box 3 |
63 | 5111 | 12.0 | 13.1 | 0.2 | 0.4 | 4.276 | 0.0250 | PCNA | proliferating cell nuclear antigen |
64 | 255738 | 2.3 | 2.4 | 0.0 | 0.2 | 1.182 | 0.3583 | PCSK9 | proprotein convertase subtilisin/kexin type 9 |
65 | 283871 | 9.2 | 9.5 | 0.2 | 0.4 | 1.469 | 0.2460 | PGP | phosphoglycolate phosphatase |
66 | 5241 | 10.2 | 11.5 | 0.2 | 0.1 | 9.929 | 0.0013 | PGR | progesterone receptor |
67 | 5293 | 3.8 | 3.0 | 0.6 | 0.2 | -2.016 | 0.1586 | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
68 | 5292 | 8.3 | 8.4 | 0.2 | 0.4 | 0.345 | 0.7554 | PIM1 | Pim-1 proto-oncogene, serine/threonine kinase |
69 | 55558 | 11.7 | 11.8 | 0.2 | 0.2 | 0.458 | 0.6717 | PLXNA3 | plexin A3 |
70 | 57804 | 14.6 | 13.8 | 0.3 | 0.4 | -2.989 | 0.0453 | POLD4 | polymerase (DNA-directed), delta 4, accessory subunit |
71 | 5443 | 3.0 | 3.3 | 0.4 | 0.6 | 0.757 | 0.5017 | POMC | proopiomelanocortin |
72 | 5468 | 2.3 | 4.0 | 0.0 | 0.5 | 5.713 | 0.0291 | PPARG | peroxisome proliferator-activated receptor gamma |
73 | 7001 | 12.0 | 12.1 | 0.1 | 0.0 | 3.370 | 0.0339 | PRDX2 | peroxiredoxin 2 |
74 | 5728 | 10.1 | 9.8 | 0.0 | 0.1 | -3.208 | 0.0714 | PTEN | phosphatase and tensin homolog |
75 | 2185 | 9.1 | 8.2 | 0.0 | 0.4 | -4.284 | 0.0472 | PTK2B | protein tyrosine kinase 2 beta |
76 | 5894 | 11.5 | 11.4 | 0.2 | 0.1 | -0.477 | 0.6613 | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase |
77 | 5923 | 3.0 | 2.3 | 1.2 | 0.1 | -0.992 | 0.4255 | RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 |
78 | 10535 | 13.6 | 13.6 | 0.1 | 0.1 | 0.277 | 0.7967 | RNASEH2A | ribonuclease H2, subunit A |
79 | 6098 | 4.4 | 2.6 | 0.3 | 0.5 | -5.609 | 0.0063 | ROS1 | ROS proto-oncogene 1 , receptor tyrosine kinase |
80 | 6185 | 12.8 | 13.3 | 0.1 | 0.1 | 6.250 | 0.0058 | RPN2 | ribophorin II |
81 | 677775 | 7.5 | 7.5 | 0.1 | 0.1 | -0.090 | 0.9327 | SCARNA5 | small Cajal body-specific RNA 5 |
82 | 29072 | 8.7 | 8.7 | 0.0 | 0.0 | 0.189 | 0.8593 | SETD2 | SET domain containing 2 |
83 | 9644 | 3.4 | 2.9 | 0.4 | 0.4 | -1.640 | 0.1765 | SH3PXD2A | SH3 and PX domains 2A |
84 | 6581 | 2.4 | 2.4 | 0.0 | 0.1 | 0.029 | 0.9782 | SLC22A3 | solute carrier family 22 (organic cation transporter), member 3 |
85 | 9748 | 9.5 | 9.6 | 0.1 | 0.2 | 0.590 | 0.6044 | SLK | STE20-like kinase |
86 | 9126 | 11.5 | 11.9 | 0.1 | 0.2 | 2.424 | 0.0778 | SMC3 | structural maintenance of chromosomes 3 |
87 | 6714 | 6.5 | 7.6 | 0.1 | 0.1 | 13.718 | 0.0002 | SRC | SRC proto-oncogene, non-receptor tyrosine kinase |
88 | 6754 | 2.5 | 2.5 | 0.3 | 0.3 | -0.160 | 0.8809 | SSTR4 | somatostatin receptor 4 |
89 | 6774 | 7.9 | 7.4 | 0.2 | 0.1 | -4.219 | 0.0140 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
90 | 6865 | 6.3 | 6.3 | 0.2 | 0.0 | 0.372 | 0.7439 | TACR2 | tachykinin receptor 2 |
91 | 7030 | 9.5 | 9.5 | 0.1 | 0.1 | 0.636 | 0.5634 | TFE3 | transcription factor binding to IGHM enhancer 3 |
92 | 7157 | 7.9 | 7.4 | 0.3 | 0.5 | -1.440 | 0.2378 | TP53 | tumor protein p53 |
93 | 7422 | 8.5 | 8.5 | 0.5 | 0.2 | 0.009 | 0.9937 | VEGFA | vascular endothelial growth factor A |
94 | 7431 | 4.9 | 6.7 | 0.5 | 0.1 | 6.548 | 0.0153 | VIM | vimentin |
95 | 7525 | 9.9 | 9.8 | 0.1 | 0.1 | -0.554 | 0.6091 | YES1 | YES proto-oncogene 1, Src family tyrosine kinase |